Skip to main content
Top

27-02-2024 | Acute Adrenal Insufficiency

Diagnosis and management of secondary adrenal crisis

Authors: Luciana Martel-Duguech, Jonathan Poirier, Isabelle Bourdeau, André Lacroix

Published in: Reviews in Endocrine and Metabolic Disorders

Login to get access

Abstract

Adrenal crisis (AC) is a life threatening acute adrenal insufficiency (AI) episode which can occur in patients with primary AI but also secondary AI (SAI), tertiary AI (TAI) and iatrogenic AI (IAI). In SAI, TAI and IAI, AC may develop when the HPA axis is unable to mount an adequate glucocorticoid response to severe stress due to pituitary or hypothalamic disruption. It manifests as an acute deterioration in multi-organ homeostasis that, if untreated, leads to shock and death. Despite the availability of effective preventive strategies, its prevalence is increasing in patients with SAI, TAI and IAI due to more frequent exogenous steroid administration, pituitary immune-related effects of immune checkpoint inhibitors and opioid use in pain management. The delayed diagnosis of acute AI which remains infrequently suspected increases the risk of AC. Its main precipitating factors are infections, emotional distress, surgery, cessation or reduction in GC doses, pituitary infarction or surgical cure of endogenous Cushing's syndrome. In patients not known previously to have SAI/TAI/IAI, recognition of its symptoms, signs, and biochemical abnormalities can be challenging and cause delay in proper diagnosis and therapy. Effective therapy of AC is rapid intravenous administration of hydrocortisone (initial bolus of 100 mg followed by 200 mg/24 h as continuous infusion or bolus of 50 mg every 6 h) and 0.9% saline. In diagnosed patients, preventive education in sick-day rules adjustment of glucocorticoid replacement and hydrocortisone parenteral self-administration must be performed repeatedly by trained health care providers. Strategies to improve the adequate preventive education in patients at risk for secondary AI should be promoted in collaboration with various medical specialist societies and patients support associations.
Literature
1.
go back to reference Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.CrossRefPubMed Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.CrossRefPubMed
2.
go back to reference Woodcock T, Barker P, Daniel S, Fletcher S, Wass JAH, Tomlinson JW, Misra U, Dattani M, Arlt W, Vercueil A. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75(5):654–63.CrossRefPubMed Woodcock T, Barker P, Daniel S, Fletcher S, Wass JAH, Tomlinson JW, Misra U, Dattani M, Arlt W, Vercueil A. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020;75(5):654–63.CrossRefPubMed
3.
go back to reference Araujo Castro M, Currás Freixes M, de Miguel Novoa P, Gracia Gimeno P, Álvarez Escolá C, Hanzu FA. SEEN guidelines for the management and prevention of acute adrenal insufficiency. Endocrinol diabetes y Nutr. 2020 Jan 1 [cited 2023 Oct 3];67(1):53–60. Available from: https://pubmed.ncbi.nlm.nih.gov/31003863/. Araujo Castro M, Currás Freixes M, de Miguel Novoa P, Gracia Gimeno P, Álvarez Escolá C, Hanzu FA. SEEN guidelines for the management and prevention of acute adrenal insufficiency. Endocrinol diabetes y Nutr. 2020 Jan 1 [cited 2023 Oct 3];67(1):53–60. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31003863/​.
4.
go back to reference Pastores SM, Annane D, Rochwerg B. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Vol. 46, Critical Care Medicine. Lippincott Williams and Wilkins; 2018. p. 146–8. Pastores SM, Annane D, Rochwerg B. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Vol. 46, Critical Care Medicine. Lippincott Williams and Wilkins; 2018. p. 146–8.
5.
go back to reference Rushworth RL, Torpy DJ. Adrenal Insufficiency in Australia: Is it Possible that the Use of Lower Dose, Short-Acting Glucocorticoids has Increased the Risk of Adrenal Crises? Horm Metab Res. 2015 Nov 18 [cited 2023 Aug 19];47(6):427–32. Available from: https://pubmed.ncbi.nlm.nih.gov/25738995/. Rushworth RL, Torpy DJ. Adrenal Insufficiency in Australia: Is it Possible that the Use of Lower Dose, Short-Acting Glucocorticoids has Increased the Risk of Adrenal Crises? Horm Metab Res. 2015 Nov 18 [cited 2023 Aug 19];47(6):427–32. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25738995/​.
6.
go back to reference Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010 [cited 2023 Aug 19];162(3):597–602. Available from: https://pubmed.ncbi.nlm.nih.gov/19955259/. Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010 [cited 2023 Aug 19];162(3):597–602. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​19955259/​.
9.
10.
go back to reference Li D, Genere N, Behnken E, Xhikola M, Abbondanza T, Vaidya A, Bancos I. Determinants of Self-reported Health Outcomes in Adrenal Insufficiency: A Multisite Survey Study. J Clin Endocrinol Metab. 2021 [cited 2023 Aug 24];106(3):E1408–19. Available from: https://pubmed.ncbi.nlm.nih.gov/32995875/. Li D, Genere N, Behnken E, Xhikola M, Abbondanza T, Vaidya A, Bancos I. Determinants of Self-reported Health Outcomes in Adrenal Insufficiency: A Multisite Survey Study. J Clin Endocrinol Metab. 2021 [cited 2023 Aug 24];106(3):E1408–19. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​32995875/​.
12.
go back to reference Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet Elsevier BV. 2021;397:613–29.CrossRef Husebye ES, Pearce SH, Krone NP, Kämpe O. Adrenal insufficiency. Lancet Elsevier BV. 2021;397:613–29.CrossRef
15.
go back to reference Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, Grossman AB, Toogood AA, Arlt W, Stewart PM, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015 [cited 2023 Sep 2];173(5):633–42. Available from: https://pubmed.ncbi.nlm.nih.gov/26294794/. Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, Grossman AB, Toogood AA, Arlt W, Stewart PM, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015 [cited 2023 Sep 2];173(5):633–42. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​26294794/​.
17.
go back to reference Tan MH, Iyengar R, Mizokami-Stout K, Yentz S, MacEachern MP, Shen LY, Redman B, Gianchandani R. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports. Clin diabetes Endocrinol. 2019 [cited 2023 Aug 22];5(1). Available from: https://pubmed.ncbi.nlm.nih.gov/30693099/. Tan MH, Iyengar R, Mizokami-Stout K, Yentz S, MacEachern MP, Shen LY, Redman B, Gianchandani R. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports. Clin diabetes Endocrinol. 2019 [cited 2023 Aug 22];5(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​30693099/​.
22.
go back to reference Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015 [cited 2023 Aug 19];100(2):407–16. Available from: https://pubmed.ncbi.nlm.nih.gov/25419882/. Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015 [cited 2023 Aug 19];100(2):407–16. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25419882/​.
26.
34.
go back to reference Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999 [cited 2023 Oct 5];140(9):4359–66. Available from: https://pubmed.ncbi.nlm.nih.gov/10465310/. Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999 [cited 2023 Oct 5];140(9):4359–66. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​10465310/​.
35.
go back to reference A E Barber 1, S M Coyle, M A Marano, E Fischer, S E Calvano, Y Fong, L L Moldawer SFL. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man - PubMed. J Immunol. 1993 [cited 2024 Jan 16];150(5):1999–2006. Available from: https://pubmed.ncbi.nlm.nih.gov/8436830/. A E Barber 1, S M Coyle, M A Marano, E Fischer, S E Calvano, Y Fong, L L Moldawer SFL. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man - PubMed. J Immunol. 1993 [cited 2024 Jan 16];150(5):1999–2006. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​8436830/​.
37.
go back to reference Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. Adv Exp Med Biol. 2015 [cited 2023 Oct 5];872:99. Available from: /pmc/articles/PMC6185996/ Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. Adv Exp Med Biol. 2015 [cited 2023 Oct 5];872:99. Available from: /pmc/articles/PMC6185996/
41.
go back to reference Samuels ME, Gallo-Payet N, Pinard S, Hasselmann C, Magne F, Patry L, Chouinard L, Schwartzentruber J, Patricia René, Sawyer N, et al. Bioinactive ACTH causing glucocorticoid deficiency. J Clin Endocrinol Metab. 2013 Feb [cited 2023 Sep 9];98(2):736–42. Available from: https://pubmed.ncbi.nlm.nih.gov/23293326/. Samuels ME, Gallo-Payet N, Pinard S, Hasselmann C, Magne F, Patry L, Chouinard L, Schwartzentruber J, Patricia René, Sawyer N, et al. Bioinactive ACTH causing glucocorticoid deficiency. J Clin Endocrinol Metab. 2013 Feb [cited 2023 Sep 9];98(2):736–42. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​23293326/​.
44.
go back to reference Van Staa TP, Leufkens HGM, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM - Mon J Assoc Physicians. 2000;93(2):105–11.CrossRef Van Staa TP, Leufkens HGM, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM - Mon J Assoc Physicians. 2000;93(2):105–11.CrossRef
46.
47.
go back to reference Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008 [cited 2023 Sep 9];50(3):537–41. Available from: https://pubmed.ncbi.nlm.nih.gov/17828747/. Einaudi S, Bertorello N, Masera N, Farinasso L, Barisone E, Rizzari C, Corrias A, Villa A, Riva F, Saracco P, et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008 [cited 2023 Sep 9];50(3):537–41. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​17828747/​.
48.
go back to reference Kuperman H, Odone Filho V, Cristofani LM, Assis De Almeida MT, Setian N, Damiani D. Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone. Horm Res Paediatr. 2012 [cited 2023 Sep 9];78(2):73–80. Available from: https://pubmed.ncbi.nlm.nih.gov/22922775/. Kuperman H, Odone Filho V, Cristofani LM, Assis De Almeida MT, Setian N, Damiani D. Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone. Horm Res Paediatr. 2012 [cited 2023 Sep 9];78(2):73–80. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​22922775/​.
49.
go back to reference Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L, Feldt-Rasmussen U. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013 [cited 2023 Sep 2];24(8):714–20. Available from: https://pubmed.ncbi.nlm.nih.gov/23806261/. Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L, Feldt-Rasmussen U. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013 [cited 2023 Sep 2];24(8):714–20. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​23806261/​.
52.
go back to reference Einarsdottir MJ, Bankvall M, Robledo-Sierra J, Rödström PO, Bergthorsdottir R, Trimpou P, Hasséus B, Ragnarsson O. Topical clobetasol treatment for oral lichen planus can cause adrenal insufficiency. Oral Dis. 2023 [cited 2024 Jan 19]; Available from: https://pubmed.ncbi.nlm.nih.gov/37103329/. Einarsdottir MJ, Bankvall M, Robledo-Sierra J, Rödström PO, Bergthorsdottir R, Trimpou P, Hasséus B, Ragnarsson O. Topical clobetasol treatment for oral lichen planus can cause adrenal insufficiency. Oral Dis. 2023 [cited 2024 Jan 19]; Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​37103329/​.
53.
go back to reference Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AFH, Diederich S, Bähr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004 [cited 2023 Sep 9];151(3):397–406. Available from: https://pubmed.ncbi.nlm.nih.gov/15362971/. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AFH, Diederich S, Bähr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004 [cited 2023 Sep 9];151(3):397–406. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​15362971/​.
55.
go back to reference LaRochelle GE, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med. 1993 [cited 2023 Sep 10];95(3):258–64. Available from: https://pubmed.ncbi.nlm.nih.gov/8368224/. LaRochelle GE, LaRochelle AG, Ratner RE, Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone. Am J Med. 1993 [cited 2023 Sep 10];95(3):258–64. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​8368224/​.
56.
go back to reference Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992 [cited 2023 Aug 26];326(4):226–30. Available from: https://pubmed.ncbi.nlm.nih.gov/1309389/. Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992 [cited 2023 Aug 26];326(4):226–30. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​1309389/​.
57.
go back to reference Borresen SW, Klose M, Baslund B, Rasmussen ÅK, Hilsted L, Friis-Hansen L, Locht H, Hansen A, Hetland ML, Lydolph MC, et al. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis. Eur J Endocrinol. 2017 [cited 2023 Aug 26];177(4):287–95. Available from: https://pubmed.ncbi.nlm.nih.gov/28877961/. Borresen SW, Klose M, Baslund B, Rasmussen ÅK, Hilsted L, Friis-Hansen L, Locht H, Hansen A, Hetland ML, Lydolph MC, et al. Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritis. Eur J Endocrinol. 2017 [cited 2023 Aug 26];177(4):287–95. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​28877961/​.
58.
go back to reference Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet (London, England). 2000 [cited 2023 Aug 26];355(9203):542–5. Available from: https://pubmed.ncbi.nlm.nih.gov/10683005/. Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet (London, England). 2000 [cited 2023 Aug 26];355(9203):542–5. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​10683005/​.
60.
go back to reference Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord. 2014 [cited 2023 Aug 26];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/25155432/. Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord. 2014 [cited 2023 Aug 26];14(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25155432/​.
62.
go back to reference Huizenga NATM, Koper JW, de Lange P, Pols HAP, Stolk RP, Grobbee DE, de Jong FH, Lamberts SWJ. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998 [cited 2023 Aug 26];83(1):47–54. Available from: https://pubmed.ncbi.nlm.nih.gov/9435415/. Huizenga NATM, Koper JW, de Lange P, Pols HAP, Stolk RP, Grobbee DE, de Jong FH, Lamberts SWJ. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998 [cited 2023 Aug 26];83(1):47–54. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​9435415/​.
63.
go back to reference Neidert S, Schuetz P, Mueller B, Christ-Crain M. Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers. Eur J Endocrinol. 2010 [cited 2023 Aug 26];162(5):943–9. Available from: https://pubmed.ncbi.nlm.nih.gov/20142368/. Neidert S, Schuetz P, Mueller B, Christ-Crain M. Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers. Eur J Endocrinol. 2010 [cited 2023 Aug 26];162(5):943–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​20142368/​.
64.
go back to reference Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, Anderson A, Huffman J, Wilson JF, Campbell H, et al. Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLoS Genet. 2014 [cited 2023 Sep 2];10(7). Available from: https://pubmed.ncbi.nlm.nih.gov/25010111/. Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, Anderson A, Huffman J, Wilson JF, Campbell H, et al. Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLoS Genet. 2014 [cited 2023 Sep 2];10(7). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25010111/​.
65.
go back to reference Hawcutt DB, Francis B, Carr DF, Jorgensen AL, Yin P, Wallin N, O’Hara N, Zhang EJ, Bloch KM, Ganguli A, et al. Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. Lancet Respir Med. 2018 [cited 2023 Sep 2];6(6):442–50. Available from: https://pubmed.ncbi.nlm.nih.gov/29551627/. Hawcutt DB, Francis B, Carr DF, Jorgensen AL, Yin P, Wallin N, O’Hara N, Zhang EJ, Bloch KM, Ganguli A, et al. Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. Lancet Respir Med. 2018 [cited 2023 Sep 2];6(6):442–50. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29551627/​.
66.
go back to reference Van Keulen BJ, Dolan C V., Andrew R, Walker BR, Hulshoff Pol HE, Boomsma DI, Rotteveel J, Finken MJJ. Heritability of Cortisol Production and Metabolism Throughout Adolescence. J Clin Endocrinol Metab. 2020 [cited 2023 Sep 2];105(2). Available from: https://pubmed.ncbi.nlm.nih.gov/31608377/. Van Keulen BJ, Dolan C V., Andrew R, Walker BR, Hulshoff Pol HE, Boomsma DI, Rotteveel J, Finken MJJ. Heritability of Cortisol Production and Metabolism Throughout Adolescence. J Clin Endocrinol Metab. 2020 [cited 2023 Sep 2];105(2). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31608377/​.
67.
68.
go back to reference Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach. Rheumatology (Oxford). 2020 [cited 2023 Aug 26];59(10):2764–73. Available from: https://pubmed.ncbi.nlm.nih.gov/32031663/. Borresen SW, Thorgrimsen TB, Jensen B, Hilsted L, Bartels EM, Feldt-Rasmussen U, Locht H. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach. Rheumatology (Oxford). 2020 [cited 2023 Aug 26];59(10):2764–73. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​32031663/​.
69.
go back to reference Valentin A, Borresen SW, Rix M, Elung-Jensen T, Sørensen SS, Feldt-Rasmussen U. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study. Nephrol Dial Transplant. 2020 [cited 2023 Aug 26];35(12):2191–7. Available from: https://pubmed.ncbi.nlm.nih.gov/31539081/. Valentin A, Borresen SW, Rix M, Elung-Jensen T, Sørensen SS, Feldt-Rasmussen U. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study. Nephrol Dial Transplant. 2020 [cited 2023 Aug 26];35(12):2191–7. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31539081/​.
73.
go back to reference Jasani KM, Boyle JA, Dick WC, Williamson J, Taylor AK, Buchanan WW. Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy. Ann Rheum Dis. 1968 [cited 2023 Aug 26];27(4):352–9. Available from: https://pubmed.ncbi.nlm.nih.gov/5666676/. Jasani KM, Boyle JA, Dick WC, Williamson J, Taylor AK, Buchanan WW. Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy. Ann Rheum Dis. 1968 [cited 2023 Aug 26];27(4):352–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​5666676/​.
74.
go back to reference Ekman B, Bachrach-Lindström M, Lindström T, Wahlberg J, Blomgren J, Arnqvist HJ. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf). 2012 [cited 2023 Aug 26];77(1):18–25. Available from: https://pubmed.ncbi.nlm.nih.gov/22288685/. Ekman B, Bachrach-Lindström M, Lindström T, Wahlberg J, Blomgren J, Arnqvist HJ. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf). 2012 [cited 2023 Aug 26];77(1):18–25. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​22288685/​.
75.
go back to reference Li T, Cunningham JL, Gilliam WP, Loukianova L, Donegan DM, Bancos I. Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids. J Clin Endocrinol Metab. 2020 [cited 2023 Aug 24];105(10):e3766. Available from: /pmc/articles/PMC7470471/. Li T, Cunningham JL, Gilliam WP, Loukianova L, Donegan DM, Bancos I. Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids. J Clin Endocrinol Metab. 2020 [cited 2023 Aug 24];105(10):e3766. Available from: /pmc/articles/PMC7470471/.
76.
go back to reference Nanus DE, Filer AD, Hughes B, Fisher BA, Taylor PC, Stewart PM, Buckley CD, McInnes I, Cooper MS, Raza K. TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis. Ann Rheum Dis. 2015 [cited 2023 Aug 26];74(2):464–9. Available from: https://pubmed.ncbi.nlm.nih.gov/24385202/. Nanus DE, Filer AD, Hughes B, Fisher BA, Taylor PC, Stewart PM, Buckley CD, McInnes I, Cooper MS, Raza K. TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis. Ann Rheum Dis. 2015 [cited 2023 Aug 26];74(2):464–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​24385202/​.
77.
go back to reference Einarsdottir MJ, Kristjansdottir HL, Bergthorsdottir R, Johannsson G, Trimpou P, Lewerin C, Ragnarsson O. Intermittent high-dose glucocorticoid treatment does not cause adrenal insufficiency in patients with diffuse large B-cell lymphoma - a prospective study. Acta Haematol. 2023 [cited 2024 Jan 19]; Available from: https://pubmed.ncbi.nlm.nih.gov/37757784/. Einarsdottir MJ, Kristjansdottir HL, Bergthorsdottir R, Johannsson G, Trimpou P, Lewerin C, Ragnarsson O. Intermittent high-dose glucocorticoid treatment does not cause adrenal insufficiency in patients with diffuse large B-cell lymphoma - a prospective study. Acta Haematol. 2023 [cited 2024 Jan 19]; Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​37757784/​.
78.
79.
go back to reference Mehta P, Meeran K, Macphie E, Abbas A, Rippin J, Jeffery RC, Reddy V, Leandro MJ, Ciurtin C, Simpson HL, et al. Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice. Lancet Rheumatol. 2021 [cited 2023 Aug 26];3(2):e92–4. Available from: https://pubmed.ncbi.nlm.nih.gov/33521672/. Mehta P, Meeran K, Macphie E, Abbas A, Rippin J, Jeffery RC, Reddy V, Leandro MJ, Ciurtin C, Simpson HL, et al. Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice. Lancet Rheumatol. 2021 [cited 2023 Aug 26];3(2):e92–4. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​33521672/​.
83.
go back to reference de Vries F, Bruin M, Lobatto DJ, Dekkers OM, Schoones JW, van Furth WR, Pereira AM, Karavitaki N, Biermasz NR, Zamanipoor Najafabadi AH. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2020 [cited 2023 Aug 26];105(3):1020–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31511863/. de Vries F, Bruin M, Lobatto DJ, Dekkers OM, Schoones JW, van Furth WR, Pereira AM, Karavitaki N, Biermasz NR, Zamanipoor Najafabadi AH. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2020 [cited 2023 Aug 26];105(3):1020–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31511863/​.
84.
85.
go back to reference Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine Consequences of Long-Term Intrathecal Administration of Opioids. J Clin Endocrinol Metab. 2000 [cited 2023 Aug 26];85(6):2215–22. Available from: https://doi.org/10.1210/jcem.85.6.6615. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine Consequences of Long-Term Intrathecal Administration of Opioids. J Clin Endocrinol Metab. 2000 [cited 2023 Aug 26];85(6):2215–22. Available from: https://​doi.​org/​10.​1210/​jcem.​85.​6.​6615.
89.
go back to reference Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Vol. 3, The Lancet Diabetes and Endocrinology. Lancet Publishing Group 2015:216–26. Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Vol. 3, The Lancet Diabetes and Endocrinology. Lancet Publishing Group 2015:216–26.
91.
go back to reference O’Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O’Kelly P, Smith D, Thompson CJ, Agha A. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). 2009 [cited 2023 Oct 9];71(5):709–14. Available from: https://pubmed.ncbi.nlm.nih.gov/19302582/. O’Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O’Kelly P, Smith D, Thompson CJ, Agha A. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). 2009 [cited 2023 Oct 9];71(5):709–14. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​19302582/​.
94.
go back to reference Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab. 2005 [cited 2023 Sep 9];90(12):6355–60. Available from: https://pubmed.ncbi.nlm.nih.gov/16144946/. Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W, Thompson CJ. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab. 2005 [cited 2023 Sep 9];90(12):6355–60. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​16144946/​.
95.
go back to reference Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab. 2012 [cited 2023 Sep 10];97(4):1194–201. Available from: https://pubmed.ncbi.nlm.nih.gov/22278423/. Hassan-Smith ZK, Sherlock M, Reulen RC, Arlt W, Ayuk J, Toogood AA, Cooper MS, Johnson AP, Stewart PM. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab. 2012 [cited 2023 Sep 10];97(4):1194–201. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​22278423/​.
96.
go back to reference Abdelmannan D, Chaiban J, Selman WR, Arafah BM. Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels. J Clin Endocrinol Metab. 2013 [cited 2023 Sep 10];98(4):1458–65. Available from: https://pubmed.ncbi.nlm.nih.gov/23450054/. Abdelmannan D, Chaiban J, Selman WR, Arafah BM. Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels. J Clin Endocrinol Metab. 2013 [cited 2023 Sep 10];98(4):1458–65. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​23450054/​.
97.
go back to reference Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 [cited 2023 Sep 10];93(7):2454–62. Available from: https://pubmed.ncbi.nlm.nih.gov/18413427/. Biller BMK, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 [cited 2023 Sep 10];93(7):2454–62. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​18413427/​.
98.
go back to reference Heinrich DA, Adolf C, Holler F, Lechner B, Schneider H, Riester A, Nirschl N, Sturm L, Wang X, Ladurner R, et al. Adrenal Insufficiency After Unilateral Adrenalectomy in Primary Aldosteronism: Long-Term Outcome and Clinical Impact. J Clin Endocrinol Metab. 2019 [cited 2023 Aug 19];104(11):5658–64. Available from: https://pubmed.ncbi.nlm.nih.gov/31225874/. Heinrich DA, Adolf C, Holler F, Lechner B, Schneider H, Riester A, Nirschl N, Sturm L, Wang X, Ladurner R, et al. Adrenal Insufficiency After Unilateral Adrenalectomy in Primary Aldosteronism: Long-Term Outcome and Clinical Impact. J Clin Endocrinol Metab. 2019 [cited 2023 Aug 19];104(11):5658–64. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31225874/​.
101.
go back to reference Yamauchi I, Taura D, Hakata T, Fujita H, Okamoto K, Ueda Y, Fujii T, Inagaki N. Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD-1 blockade therapy. Clin Endocrinol (Oxf). 2021 [cited 2023 Aug 24];94(2):258–68. Available from: https://pubmed.ncbi.nlm.nih.gov/33037658/. Yamauchi I, Taura D, Hakata T, Fujita H, Okamoto K, Ueda Y, Fujii T, Inagaki N. Clinical features and thyroid dysfunction in adverse events involving the pituitary gland during PD-1 blockade therapy. Clin Endocrinol (Oxf). 2021 [cited 2023 Aug 24];94(2):258–68. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​33037658/​.
102.
go back to reference Levy M, Abeillon J, Dalle S, Assaad S, Borson-Chazot F, Disse E, Raverot G, Cugnet-Anceau C. Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up. J Clin Med. 2020 [cited 2023 Aug 24];9(10):1–10. Available from: /pmc/articles/PMC7601962/. Levy M, Abeillon J, Dalle S, Assaad S, Borson-Chazot F, Disse E, Raverot G, Cugnet-Anceau C. Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up. J Clin Med. 2020 [cited 2023 Aug 24];9(10):1–10. Available from: /pmc/articles/PMC7601962/.
103.
go back to reference Zhai Y, Ye X, Hu F, Xu J, Guo X, Zhuang Y, He J. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. J Immunother cancer. 2019 [cited 2023 Aug 26];7(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31694698/. Zhai Y, Ye X, Hu F, Xu J, Guo X, Zhuang Y, He J. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. J Immunother cancer. 2019 [cited 2023 Aug 26];7(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​31694698/​.
104.
go back to reference Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018 [cited 2023 Aug 19];4(2):173–82. Available from: https://pubmed.ncbi.nlm.nih.gov/28973656/. Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018 [cited 2023 Aug 19];4(2):173–82. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​28973656/​.
105.
go back to reference Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 [cited 2023 Aug 26];21(4):749–55. Available from: https://pubmed.ncbi.nlm.nih.gov/25538262/. Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 [cited 2023 Aug 26];21(4):749–55. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25538262/​.
106.
107.
go back to reference Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell. 2001 [cited 2023 Sep 9];104(6):849–59. Available from: https://pubmed.ncbi.nlm.nih.gov/11290323/. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell. 2001 [cited 2023 Sep 9];104(6):849–59. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​11290323/​.
109.
go back to reference Quentien MH, Delemer B, Papadimitriou DT, Souchon PF, Jaussaud R, Pagnier A, Munzer M, Jullien N, Reynaud R, Galon-Faure N, et al. Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. J Clin Endocrinol Metab. 2012 [cited 2023 Sep 9];97(1). Available from: https://pubmed.ncbi.nlm.nih.gov/22013103/. Quentien MH, Delemer B, Papadimitriou DT, Souchon PF, Jaussaud R, Pagnier A, Munzer M, Jullien N, Reynaud R, Galon-Faure N, et al. Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. J Clin Endocrinol Metab. 2012 [cited 2023 Sep 9];97(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​22013103/​.
110.
go back to reference Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezène F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab. 2001 [cited 2023 Sep 9];86(9):4529–35. Available from: https://pubmed.ncbi.nlm.nih.gov/11549703/. Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezène F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab. 2001 [cited 2023 Sep 9];86(9):4529–35. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​11549703/​.
111.
go back to reference Rajab A, Kelberman D, De castro SCP, Biebermann H, Shaikh H, Pearce K, Hall CM, Shaikh G, Gerrelli D, Grueters A, et al. Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet. 2008 [cited 2023 Sep 9];17(14):2150–9. Available from: https://pubmed.ncbi.nlm.nih.gov/18407919/. Rajab A, Kelberman D, De castro SCP, Biebermann H, Shaikh H, Pearce K, Hall CM, Shaikh G, Gerrelli D, Grueters A, et al. Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet. 2008 [cited 2023 Sep 9];17(14):2150–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​18407919/​.
112.
go back to reference Tajima T, Hattori T, Nakajima T, Okuhara K, Tsubaki J, Fujieda K. A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica. Endocr J. 2007 [cited 2023 Sep 9];54(4):637–41. Available from: https://pubmed.ncbi.nlm.nih.gov/17527005/. Tajima T, Hattori T, Nakajima T, Okuhara K, Tsubaki J, Fujieda K. A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica. Endocr J. 2007 [cited 2023 Sep 9];54(4):637–41. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​17527005/​.
113.
go back to reference Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, Stifani S, Brickman JM, Arnhold IJP, Dattani MT. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest. 2003 [cited 2023 Sep 9];112(8):1192–201. Available from: https://pubmed.ncbi.nlm.nih.gov/14561704/. Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, Stifani S, Brickman JM, Arnhold IJP, Dattani MT. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest. 2003 [cited 2023 Sep 9];112(8):1192–201. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​14561704/​.
114.
go back to reference Shimada A, Takagi M, Nagashima Y, Miyai K, Hasegawa Y. A Novel Mutation in OTX2 Causes Combined Pituitary Hormone Deficiency, Bilateral Microphthalmia, and Agenesis of the Left Internal Carotid Artery. Horm Res Paediatr. 2016 [cited 2023 Sep 9];86(1):62–9. Available from: https://pubmed.ncbi.nlm.nih.gov/27299576/. Shimada A, Takagi M, Nagashima Y, Miyai K, Hasegawa Y. A Novel Mutation in OTX2 Causes Combined Pituitary Hormone Deficiency, Bilateral Microphthalmia, and Agenesis of the Left Internal Carotid Artery. Horm Res Paediatr. 2016 [cited 2023 Sep 9];86(1):62–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​27299576/​.
124.
go back to reference Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–921.CrossRefPubMed Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH. Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–921.CrossRefPubMed
125.
go back to reference Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol (Oxf). 2017 [cited 2023 Sep 2];86(2):177–84. Available from: https://pubmed.ncbi.nlm.nih.gov/27616279/. Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol (Oxf). 2017 [cited 2023 Sep 2];86(2):177–84. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​27616279/​.
127.
go back to reference Kazlauskaite R, Evans AT, Villabona C V., Abdu TAM, Ambrosi B, Atkinson AB, Cheung HC, Clayton RN, Courtney CH, Gonc EN, et al. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab. 2008 [cited 2023 Sep 2];93(11):4245–53. Available from: https://pubmed.ncbi.nlm.nih.gov/18697868/. Kazlauskaite R, Evans AT, Villabona C V., Abdu TAM, Ambrosi B, Atkinson AB, Cheung HC, Clayton RN, Courtney CH, Gonc EN, et al. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab. 2008 [cited 2023 Sep 2];93(11):4245–53. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​18697868/​.
128.
go back to reference Kane KF, Emery P, Sheppard MCSP. Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test. QJM. 1995;88(4):263–7.PubMed Kane KF, Emery P, Sheppard MCSP. Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test. QJM. 1995;88(4):263–7.PubMed
129.
go back to reference Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2006 [cited 2023 Sep 2];91(1):43–7. Available from: https://pubmed.ncbi.nlm.nih.gov/16249286/. Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2006 [cited 2023 Sep 2];91(1):43–7. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​16249286/​.
130.
go back to reference Ospina NS, Nofal A Al, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016 [cited 2023 Oct 9];101(2):427–34. Available from: https://pubmed.ncbi.nlm.nih.gov/26649617/. Ospina NS, Nofal A Al, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016 [cited 2023 Oct 9];101(2):427–34. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​26649617/​.
132.
go back to reference Plumpton, F.S. & Besser GM. The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. Br J Surg. 1969;(56):216–9. Plumpton, F.S. & Besser GM. The adrenocortical response to surgery and insulin-induced hypoglycemia in corticosteroid-treated and normal subjects. Br J Surg. 1969;(56):216–9.
133.
go back to reference Ueland GA, Methlie P, Øksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Ræder M, Dahlqvist P, Dahl SR, et al. The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS. J Clin Endocrinol Metab. 2018 [cited 2023 Sep 2];103(4):1696–703. Available from: https://pubmed.ncbi.nlm.nih.gov/29452421/. Ueland GA, Methlie P, Øksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Ræder M, Dahlqvist P, Dahl SR, et al. The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS. J Clin Endocrinol Metab. 2018 [cited 2023 Sep 2];103(4):1696–703. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29452421/​.
134.
go back to reference Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016 [cited 2023 Sep 2];77(5):620–2. Available from: https://pubmed.ncbi.nlm.nih.gov/27449530/. Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II assay. Ann Endocrinol (Paris). 2016 [cited 2023 Sep 2];77(5):620–2. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​27449530/​.
136.
go back to reference Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, Findling JW. New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. 2021 [cited 2023 Aug 24];5(4):1–11. Available from: https://academic.oup.com/jes1. Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, Findling JW. New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays. J Endocr Soc. 2021 [cited 2023 Aug 24];5(4):1–11. Available from: https://​academic.​oup.​com/​jes1.
139.
go back to reference Ambroziak U, Kondracka A, Bartoszewicz Z, Krasnodębska-Kiljańska M, Bednarczuk T. The morning and late-night salivary cortisol ranges for healthy women may be used in pregnancy. Clin Endocrinol (Oxf). 2015;83(6):774–8.CrossRefPubMed Ambroziak U, Kondracka A, Bartoszewicz Z, Krasnodębska-Kiljańska M, Bednarczuk T. The morning and late-night salivary cortisol ranges for healthy women may be used in pregnancy. Clin Endocrinol (Oxf). 2015;83(6):774–8.CrossRefPubMed
142.
go back to reference Debono M, Elder CJ, Lewis J, Fearnside J, Caunt S, Dixon S, Jacques RM, Newell-Price J, Whitaker MJ, Keevil B, et al. Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evid. 2023 Jan 24;2(2). Debono M, Elder CJ, Lewis J, Fearnside J, Caunt S, Dixon S, Jacques RM, Newell-Price J, Whitaker MJ, Keevil B, et al. Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. NEJM Evid. 2023 Jan 24;2(2).
143.
go back to reference Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol. 2014 [cited 2023 Sep 2];14(1). Available from: https://pubmed.ncbi.nlm.nih.gov/25071417/. Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol. 2014 [cited 2023 Sep 2];14(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​25071417/​.
147.
go back to reference Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, Fazal-Sanderson V, Komninos J, O’Neil DM, Vassiliadi DA, et al. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. J Clin Endocrinol Metab. 2020 [cited 2024 Jan 20];105(7). Available from: https://pubmed.ncbi.nlm.nih.gov/32170323/. Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, Fazal-Sanderson V, Komninos J, O’Neil DM, Vassiliadi DA, et al. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. J Clin Endocrinol Metab. 2020 [cited 2024 Jan 20];105(7). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​32170323/​.
154.
155.
go back to reference Repping-Wuts HJWJ, Stikkelbroeck NMML, Noordzij A, Kerstens M, Hermus ARMM. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol. 2013 [cited 2023 Sep 27];169(1):17–22. Available from: https://pubmed.ncbi.nlm.nih.gov/23636446/. Repping-Wuts HJWJ, Stikkelbroeck NMML, Noordzij A, Kerstens M, Hermus ARMM. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol. 2013 [cited 2023 Sep 27];169(1):17–22. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​23636446/​.
157.
go back to reference Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord. 2012 [cited 2023 Sep 27];12. Available from: https://pubmed.ncbi.nlm.nih.gov/22695167/. Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord. 2012 [cited 2023 Sep 27];12. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​22695167/​.
158.
160.
go back to reference Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W, Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab. 2007 [cited 2023 Sep 27];92(10):3912–22. Available from: https://pubmed.ncbi.nlm.nih.gov/17684047/. Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W, Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab. 2007 [cited 2023 Sep 27];92(10):3912–22. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​17684047/​.
161.
go back to reference Daae E, Feragen KB, Nermoen I, Falhammar H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine. 2018 [cited 2023 Sep 27];62(1):3–13. Available from: https://pubmed.ncbi.nlm.nih.gov/30128958/. Daae E, Feragen KB, Nermoen I, Falhammar H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine. 2018 [cited 2023 Sep 27];62(1):3–13. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​30128958/​.
163.
go back to reference Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, Nordenskjöld A, Frisén L, Nordenström A. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab. 2014 [cited 2023 Sep 27];99(4):1425–32. Available from: https://pubmed.ncbi.nlm.nih.gov/24476073/. Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, Nordenskjöld A, Frisén L, Nordenström A. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab. 2014 [cited 2023 Sep 27];99(4):1425–32. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​24476073/​.
165.
go back to reference Werumeus Buning J, Touw DJ, Brummelman P, Dullaart RPF, van den Berg G, van der Klauw MM, Kamp J, Wolffenbuttel BHR, van Beek AP. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial. Metabolism. 2017 [cited 2023 Sep 27];71:7–16. Available from: https://pubmed.ncbi.nlm.nih.gov/28521880/. Werumeus Buning J, Touw DJ, Brummelman P, Dullaart RPF, van den Berg G, van der Klauw MM, Kamp J, Wolffenbuttel BHR, van Beek AP. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial. Metabolism. 2017 [cited 2023 Sep 27];71:7–16. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​28521880/​.
166.
go back to reference Sorgdrager FJH, Buning JW, Bos EH, Van Beek AP, Kema IP. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2018 [cited 2023 Sep 27];103(9):3411–9. Available from: https://pubmed.ncbi.nlm.nih.gov/29982583/. Sorgdrager FJH, Buning JW, Bos EH, Van Beek AP, Kema IP. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2018 [cited 2023 Sep 27];103(9):3411–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29982583/​.
167.
go back to reference Burger-Stritt S, Kardonski P, Pulzer A, Meyer G, Quinkler M, Hahner S. Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin Endocrinol (Oxf). 2018 [cited 2023 Sep 27];89(1):22–9. Available from: https://pubmed.ncbi.nlm.nih.gov/29617051/. Burger-Stritt S, Kardonski P, Pulzer A, Meyer G, Quinkler M, Hahner S. Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin Endocrinol (Oxf). 2018 [cited 2023 Sep 27];89(1):22–9. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​29617051/​.
170.
go back to reference Kampmeyer D, Lehnert H, Moenig H, Haas CS, Harbeck B. A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: An interdisciplinary and multicentre evaluation. Eur J Intern Med. 2016 [cited 2023 Sep 27];33:e13–5. Available from: https://pubmed.ncbi.nlm.nih.gov/27108240/. Kampmeyer D, Lehnert H, Moenig H, Haas CS, Harbeck B. A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: An interdisciplinary and multicentre evaluation. Eur J Intern Med. 2016 [cited 2023 Sep 27];33:e13–5. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​27108240/​.
172.
Metadata
Title
Diagnosis and management of secondary adrenal crisis
Authors
Luciana Martel-Duguech
Jonathan Poirier
Isabelle Bourdeau
André Lacroix
Publication date
27-02-2024
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-024-09877-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.